China Shineway Pharmaceutical Group Limited

OTCPK:CSWY.F Stock Report

Market Cap: US$684.3m

China Shineway Pharmaceutical Group Past Earnings Performance

Past criteria checks 5/6

China Shineway Pharmaceutical Group has been growing earnings at an average annual rate of 8.9%, while the Pharmaceuticals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 11.8% per year. China Shineway Pharmaceutical Group's return on equity is 13.3%, and it has net margins of 19.5%.

Key information

8.9%

Earnings growth rate

10.9%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate11.8%
Return on equity13.3%
Net Margin19.5%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How China Shineway Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:CSWY.F Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 234,5348832,323137
31 Mar 234,2428032,215127
31 Dec 223,9517232,107117
30 Sep 223,7186512,004117
30 Jun 223,4855791,902116
31 Mar 223,3545681,832115
31 Dec 213,2245571,763113
30 Sep 213,1224531,676109
30 Jun 213,0203501,590105
31 Mar 212,8383221,528102
31 Dec 202,6562951,466100
30 Sep 202,5923821,42588
30 Jun 202,5284691,38477
31 Mar 202,6174861,39390
31 Dec 192,7065031,402103
30 Sep 192,6705201,367102
30 Jun 192,6335371,332100
31 Mar 192,6025211,293114
31 Dec 182,5705061,254128
30 Sep 182,4925161,174136
30 Jun 182,4135261,095144
31 Mar 182,166489929120
31 Dec 171,92045276397
30 Sep 171,89747470881
30 Jun 171,87349665366
31 Mar 171,93354265170
31 Dec 161,99358964874
30 Sep 161,93556965979
30 Jun 161,87754966984
31 Mar 161,96660367376
31 Dec 152,05565867869
30 Sep 152,14767269173
30 Jun 152,23968570578
31 Mar 152,23469570179
31 Dec 142,22970569780
30 Sep 142,22870469779
30 Jun 142,22770369878
31 Mar 142,20769369981
31 Dec 132,18768470183
30 Sep 132,18868168979
30 Jun 132,18967867875
31 Mar 132,16166367771
31 Dec 122,13264867668

Quality Earnings: CSWY.F has high quality earnings.

Growing Profit Margin: CSWY.F's current net profit margins (19.5%) are higher than last year (16.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CSWY.F's earnings have grown by 8.9% per year over the past 5 years.

Accelerating Growth: CSWY.F's earnings growth over the past year (52.4%) exceeds its 5-year average (8.9% per year).

Earnings vs Industry: CSWY.F earnings growth over the past year (52.4%) exceeded the Pharmaceuticals industry -17.3%.

Return on Equity

High ROE: CSWY.F's Return on Equity (13.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.